~~<i id='88AC10DA60'><strike id='88AC10DA60'><tt id='88AC10DA60'><pre id='88AC10DA60'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

author：comprehensive 2025-09-05 07:02:45 - browse：9698

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Overprescribed: High cost isn't America's only drug problem

Wikipedia

hotspot

focus

Wikipedia

hotspot

focus

ResearcherHaripriyaSathyanarayananobservingasapediatricparticipantexploresahospitalroominvirtualreal

WSS

Harvard scientists, with Google, unveil the most detailed brain map ever

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Covid silver lining: Unprecedented look at human immune system

Lessons Learned: This is why you network to find that industry job you want

More regulation could be coming for drug ads

Young boy dies in trial for Pfizer Duchenne gene therapy

hotspot

Wikipedia

As demand for Covid shots wanes, Moderna seeks its next success

Young boy dies in trial for Pfizer Duchenne gene therapy

In age of alternative facts, a scholarly course on calling out crap

Overprescribed: High cost isn't America's only drug problem

In Memoriam: Notable people who died in 2023

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

BioMarin wins approval for gene therapy to treat hemophilia A

Hospitals use virtual reality to design more inclusive rooms for kids

Apple is now the first public company to be valued at $3 trillion

Study: Black kids more likely to die after surgery than white kids

hotspot

Florida Supreme Court upholds state's abortion ban

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Bird flu in dairy cattle: New measures to control spread to humans

Choosing scientific sides in the fight against Alzheimer's

Germany receives 178 compensation applications from gay servicepeople over discrimination

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

focus

Wikipedia

hotspot

focus